// App-Quantinova.ai

PB1672 : REDEFINING OUTCOMES IN MULTIPLE MYELOMA IN COVID-19 INFECTED PATIENTS. RECONSIDERING THE THROMBOSIS AND INFECTIVE RISK.

Researchers

Presenter

  • Harberth Fernandez-Leyva

Principal Investigators

  • N/A

Medical Centers

  • Haematology,NHS,North Warnborough,United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Infectious Diseases (ID)

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Multiple Myeloma

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved